Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration.
Danilo IannettaMichele De MariaElena BollettaValentina MastrofilippoAntonio MoramarcoLuigi FontanaPublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
PPV with rtPA subretinal injection and SF6 tamponade is a safe and effective technique in displacing acute SMHs secondary to neovascular AMD. It is recommended to perform within 14 days from the onset of the symptoms to achieve BCVA improvement at 12 months and proper imaging to plan future anti-VEG treatment.
Keyphrases
- age related macular degeneration
- liver failure
- respiratory failure
- drug induced
- aortic dissection
- ultrasound guided
- high resolution
- hepatitis b virus
- current status
- physical activity
- mass spectrometry
- depressive symptoms
- fluorescence imaging
- vascular endothelial growth factor
- mechanical ventilation
- endothelial cells